Back to top

Analyst Blog

A.M. Best Co. reiterated theissuer credit ratings (“ICR”) of ‘bbb’of Genworth Financial Inc. (GNW - Analyst Report) and all of its existing debt ratings.

Concurrently, the credit rating agency reiterated the financial strength rating of ‘A’ (Excellent) and ICR of  ‘a’ of Genworth Life Insurance Company, Genworth Life Insurance Company of New York and Genworth Life and Annuity Insurance Company, the primary life/health subsidiaries of Genworth.

The outlook for all ratings is negative.

The rating affirmations came on the back of the company’s consistency in delivering better operational performances as well as growth in its life segment. Better operational performances were backed by the company’s strong market position in long-term care, fixed annuities, life and wealth management besides favorable operating company liquidity and adequate risk-adjusted capital.

The rating agency favors Genworth’s divestments of less capital-intensive products, product hedging, enhancement of investment portfolio’s credit standard and core statutory operating earnings.

However, A. M. Best is of opinion that the announcement to push forward the partial initial publics offering of the Australian mortgage business, sluggish sales in the international lifestyle protection business and continued loss in the U.S. mortgage business could weigh on the  performance of life/health operations.

The rating agency noted that there has been a remarkable change in the company portfolio following the divestment of Medicare supplement business and discontinuation of the individual and group variable annuity business. These actions have lowered the company’s diversification of life/health business.

Also, the rating agency expects considerable inforce block of long-term care to continually weigh on the earnings. Further, the U.S. mortgage insurance business continues to incur huge losses, though the magnitude has lowered. All these factors, combined, led to a negative outlook.

Nevertheless, enhanced operating results across all lines of business coupled with better interest coverage and risk-adjusted capital maintained at present levels could trigger outlook upgrade.

On the flip side, the outlook will be subject to downgrade if operating results deteriorate, financial leverage increases, coverage ratios worsen, credit impairments swell and risk-adjusted capital dwindle.

In early May, MetLife Inc. (MET - Analyst Report), which competes with Genworth was affirmed long-term counterparty credit rating at 'A-' by Standard & Poor's Ratings Services. The rating agency also affirmed long-term counterparty credit at 'AA-' and financial strength ratings on its subsidiaries. The outlook was also revised to stable from negative.

Genworth carries a Zacks #3 Rank, implying a short-term Hold rating, with no clear directional pressure in the near term.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 2.99 +2.75%
CTPARTNERS… CTP 16.20 +2.02%
THE PANTRY… PTRY 20.99 +1.92%
CHINA BIOLO… CBPO 46.88 +1.77%
PIPER JAFFR… PJC 54.50 +1.62%